View in EDS HTML Full Text PDF Full Text

A Phase Ib Study of Indirect Immunization with Oregovomab and Toll-like-Receptor-3 Stimulation with Hiltonol® in Patients with Recurrent Platinum-Resistant Ovarian Cancer.

Saved in:
Bibliographic Details
Title: A Phase Ib Study of Indirect Immunization with Oregovomab and Toll-like-Receptor-3 Stimulation with Hiltonol® in Patients with Recurrent Platinum-Resistant Ovarian Cancer.
Authors: Holloway RW; Gynecologic Oncology Program, AdventHealth Cancer Institute, Orlando, FL 32804, USA., Temkin SM; Division of Gynecologic Oncology, Virginia Commonwealth University, Richmond, VA 23298, USA., Gordon SW; Division of Gynecologic Oncology, Virginia Commonwealth University, Richmond, VA 23298, USA., Gupta S; CanariaBio, Inc., Seoul 06044, Gyeonggi-do, Republic of Korea., Jada SR; CanariaBio, Inc., Seoul 06044, Gyeonggi-do, Republic of Korea., Ahmad S; Gynecologic Oncology Program, AdventHealth Cancer Institute, Orlando, FL 32804, USA., McGuire WP; Division of Gynecologic Oncology, Virginia Commonwealth University, Richmond, VA 23298, USA.
Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2025 Sep 24; Vol. 32 (10). Date of Electronic Publication: 2025 Sep 24.
Publication Type: Journal Article; Clinical Trial, Phase I
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729 (Electronic) Linking ISSN: 11980052 NLM ISO Abbreviation: Curr Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41149451
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Phase Ib Study of Indirect Immunization with Oregovomab and Toll-like-Receptor-3 Stimulation with Hiltonol<superscript>®</superscript> in Patients with Recurrent Platinum-Resistant Ovarian Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Holloway+RW%22">Holloway RW</searchLink>; Gynecologic Oncology Program, AdventHealth Cancer Institute, Orlando, FL 32804, USA.<br /><searchLink fieldCode="AU" term="%22Temkin+SM%22">Temkin SM</searchLink>; Division of Gynecologic Oncology, Virginia Commonwealth University, Richmond, VA 23298, USA.<br /><searchLink fieldCode="AU" term="%22Gordon+SW%22">Gordon SW</searchLink>; Division of Gynecologic Oncology, Virginia Commonwealth University, Richmond, VA 23298, USA.<br /><searchLink fieldCode="AU" term="%22Gupta+S%22">Gupta S</searchLink>; CanariaBio, Inc., Seoul 06044, Gyeonggi-do, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jada+SR%22">Jada SR</searchLink>; CanariaBio, Inc., Seoul 06044, Gyeonggi-do, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Ahmad+S%22">Ahmad S</searchLink>; Gynecologic Oncology Program, AdventHealth Cancer Institute, Orlando, FL 32804, USA.<br /><searchLink fieldCode="AU" term="%22McGuire+WP%22">McGuire WP</searchLink>; Division of Gynecologic Oncology, Virginia Commonwealth University, Richmond, VA 23298, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502503%22">Current oncology (Toronto, Ont.)</searchLink> [Curr Oncol] 2025 Sep 24; Vol. 32 (10). <i>Date of Electronic Publication: </i>2025 Sep 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase I
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>9502503 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1718-7729 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211980052%22">11980052 </searchLink><i>NLM ISO Abbreviation: </i>Curr Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41149451
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/curroncol32100532
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: A Phase Ib Study of Indirect Immunization with Oregovomab and Toll-like-Receptor-3 Stimulation with Hiltonol® in Patients with Recurrent Platinum-Resistant Ovarian Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Holloway RW
      – PersonEntity:
          Name:
            NameFull: Temkin SM
      – PersonEntity:
          Name:
            NameFull: Gordon SW
      – PersonEntity:
          Name:
            NameFull: Gupta S
      – PersonEntity:
          Name:
            NameFull: Jada SR
      – PersonEntity:
          Name:
            NameFull: Ahmad S
      – PersonEntity:
          Name:
            NameFull: McGuire WP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 09
              Text: 2025 Sep 24
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1718-7729
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Current oncology (Toronto, Ont.)
              Type: main
ResultId 1